Inovio Pharma diskutieren
Inovio Pharma
WKN: A115GK / Symbol: INO / Name: Inovio Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,53 €
-2,24 %
Buy Inovio Pharma
Buy Inovio Pharma
Buy Inovio Pharma
Sell Inovio Pharma
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $4.00 price target on the stock.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at Stephens. They set an "overweight" rating and a $20.00 price target on the stock.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $40.00 to $33.00. They now have an "outperform" rating on the stock.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $33.00 to $15.00. They now have an "outperform" rating on the stock.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $15.00 to $13.00. They now have an "outperform" rating on the stock.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $5.00 price target on the stock.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at UBS Group AG.
Ratings data for INO provided by MarketBeat
Neueste Beiträge
HC_Wainwright in Biocryst Pharmaceuticals diskutieren